NCT04267198

Brief Summary

Every year approximately 15,000 Veterans are hospitalized for stroke, and up to 40% of those Veterans will experience stroke-related language impairment (i.e., aphasia). Stroke-induced aphasia results in increased healthcare costs and decreased quality of life. As the population of Veterans continues to age, there will be an increasing number for Veterans living with the aphasia and its consequences. Those Veterans deserve to receive aphasia treatment designed to facilitate the best possible outcomes. In the proposed study, the investigators will investigate optimal treatment intensity and predictors of treatment response for a novel word retrieval treatment. The knowledge the investigators gain will have direct implications for the selecting the right treatment approach for the right Veteran.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
32

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started May 2021

Longer than P75 for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

February 4, 2020

Completed
8 days until next milestone

First Posted

Study publicly available on registry

February 12, 2020

Completed
1.3 years until next milestone

Study Start

First participant enrolled

May 24, 2021

Completed
3.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2025

Completed
6 months until next milestone

Study Completion

Last participant's last visit for all outcomes

September 30, 2025

Completed
Last Updated

October 22, 2025

Status Verified

October 1, 2025

Enrollment Period

3.9 years

First QC Date

February 4, 2020

Last Update Submit

October 21, 2025

Conditions

Keywords

aphasialanguagerehabilitationspeech-language pathology

Outcome Measures

Primary Outcomes (11)

  • Number of correctly named pictures

    Change in the ability to correctly name 10 trained and 10 untrained pictures will be measured at 4 time points

    Through study completion, an average of 6 months; Change from baseline to 3 weeks (post massed-INT) or 12 weeks (post distributed-INT), change at 3 months post-treatment, change at 6 months post-treatment

  • Number of correctly generated category members

    Change in the ability to correctly name 5 trained and 5 untrained category members will be measured at 4 time points

    Through study study completion, an average of 6 months; Change from baseline to 3 weeks (post m-INT) or 12 weeks (post d-INT), change at 3 months post-treatment, change at 6 months post-treatment

  • Western Aphasia Battery

    This standardized assessment will be administered at baseline to investigate language predictors of treatment outcome

    Baseline

  • Boston Naming Test

    This standardized assessment will be administered at baseline to investigate language predictors of treatment outcome

    Baseline

  • Test of Everyday Attention

    This standardized assessment will be administered at baseline to investigate cognitive predictors of treatment outcome.

    Baseline

  • Brief Visuospatial Memory Test-Revised

    This standardized assessment will be administered at baseline to investigate cognitive predictors of treatment outcome.

    Baseline

  • Hopkins Verbal Learning Test-Revised

    This standardized assessment will be administered at baseline to investigate cognitive predictors of treatment outcome.

    Baseline

  • Digit Span Backwards

    This standardized assessment will be administered at baseline to investigate cognitive predictors of treatment outcome.

    Baseline

  • Delis-Kaplan Executive Function System (D-KEFS) Sorting

    This standardized assessment will be administered at baseline to investigate cognitive predictors of treatment outcome.

    Baseline

  • Structural MRI scan

    Tissue health (from structural scan) will be obtained at baseline to investigate neural predictors of treatment outcome.

    Baseline

  • Functional MRI scan

    Task-based activation location (from functional MRI scans) will be obtained at baseline to investigate neural predictors of treatment outcome.

    Baseline

Secondary Outcomes (1)

  • Delis-Kaplan Executive Function System (D-KEFS) Trails

    Baseline

Study Arms (2)

Massed Intention Treatment (massed-INT)

ACTIVE COMPARATOR

Participants will receive 30 hours of Intention Treatment (INT) over 3 weeks.

Behavioral: Intention Treatment for Anomia

Distributed Intention Treatment (distributed-INT)

ACTIVE COMPARATOR

Participants will receive 30 hours of Intention Treatment (INT) over 12 weeks.

Behavioral: Intention Treatment for Anomia

Interventions

Word retrieval treatment for aphasia that engages right hemisphere intention mechanisms using a left-hand circular gesture.

Distributed Intention Treatment (distributed-INT)Massed Intention Treatment (massed-INT)

Eligibility Criteria

Age21 Years - 89 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • English as primary language
  • \> 6 months post-onset a left-hemisphere stroke. Multiple strokes are acceptable as long as they are confined to the left hemisphere.
  • Diagnosis of aphasia
  • Presence of word retrieval deficits
  • Adequate comprehension as judged by ability to complete two-step commands on the Western Aphasia Battery.

You may not qualify if:

  • Severe apraxia of speech or dysarthria
  • Clinically significant depression
  • For MRI safety: implanted medical devices, metal in the body and claustrophobia.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Atlanta VA Medical and Rehab Center, Decatur, GA

Decatur, Georgia, 30033-4004, United States

Location

MeSH Terms

Conditions

AphasiaStrokeLanguage

Condition Hierarchy (Ancestors)

Speech DisordersLanguage DisordersCommunication DisordersNeurobehavioral ManifestationsNeurologic ManifestationsNervous System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesVascular DiseasesCardiovascular DiseasesCommunicationBehavior

Study Officials

  • Amy D. Rodriguez, PhD

    Atlanta VA Medical and Rehab Center, Decatur, GA

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
OUTCOMES ASSESSOR
Masking Details
Assessments will be conducted by study staff blind to treatment condition
Purpose
TREATMENT
Intervention Model
PARALLEL
Model Details: Delayed-start controlled trial with stratification across two groups (massed-INT, distributed-INT) based on severity of word retrieval deficits.
Sponsor Type
FED
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 4, 2020

First Posted

February 12, 2020

Study Start

May 24, 2021

Primary Completion

March 31, 2025

Study Completion

September 30, 2025

Last Updated

October 22, 2025

Record last verified: 2025-10

Data Sharing

IPD Sharing
Will not share

Locations